REL (Proto-oncogene c-Rel) variants and mutations
REL (also known as Proto-oncogene c-Rel) is a human protein-coding gene encoding a proto-oncogene c-Rel protein. It provides the c-Rel NF-kappaB transcription factor, which regulates lymphocyte activation, survival, cytokine production, and immune differentiation. Amplification or persistent activation contributes to several lymphoid malignancies and inflammatory states. This analysis covers 278 REL variants and mutations. Of these, 96% have computational variant effect predictions. Disease context includes immunodeficiency 92, rheumatoid arthritis, and psoriasis. Example REL variants include A2S, A2T, and A2D.
Variant analysis overview
- Gene: REL
- Protein: Proto-oncogene c-Rel
- UniProt accession: Q04864
- Organism: Homo sapiens
- Variants analyzed: 278
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 97 unspecified-consequence records; 116 missense variants; 51 synonymous variants; 6 frameshift variants; 3 splice-region variants; 3 stop-gained variants; 2 in-frame deletions
- Prediction scores: 266 variants have prediction scores (96% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: immunodeficiency 92, rheumatoid arthritis, psoriasis, lymphoid neoplasm, neurodegenerative disease, bile duct carcinoma, autoimmune disorder of central nervous system, ovarian endometrioid adenocarcinoma with squamous differentiation, gliomatosis cerebri, carcinoma of liver and intrahepatic biliary tract, psoriasis vulgaris, atopic eczema.
Protein structure and variant hotspots
- Protein features: 1 domains; 3 post-translational modification sites.
- Structural context: 202 variants have structural context.
- PTM context: 5 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable REL variants
Examples include A2S, A2T, A2D, A2V, A2A, S3P, S3Y, S3S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2S (p.Ala2Ser), rs1672944674, gnomAD 2-60881844-G-T, REVEL 0.11, MetaLR 0.05
- A2T (p.Ala2Thr), gnomAD 2-60881844-G-A, REVEL 0.10, MetaLR 0.07
- A2D (p.Ala2Asp), gnomAD 2-60881845-C-A, REVEL 0.14, MetaLR 0.09
- A2V (p.Ala2Val), gnomAD 2-60881845-C-T, REVEL 0.16, MetaLR 0.05
- A2A (p.Ala2Ala), gnomAD 2-60881846-C-A, CADD 14.20
- S3P (p.Ser3Pro), gnomAD 2-60881847-T-C, REVEL 0.16, MetaLR 0.08
- S3Y (p.Ser3Tyr), gnomAD 2-60881848-C-A, REVEL 0.14, MetaLR 0.14
- S3S (p.Ser3Ser), gnomAD 2-60881849-C-T, CADD 5.65
- G4V (p.Gly4Val), gnomAD 2-60881847-TC-T, CADD 30.00
- G4C (p.Gly4Cys), gnomAD 2-60881850-G-T, REVEL 0.08, MetaLR 0.10
- G4S (p.Gly4Ser), gnomAD 2-60881850-G-A, REVEL 0.06, MetaLR 0.11
- G4D (p.Gly4Asp), rs1673219478, gnomAD 2-60891683-G-A, REVEL 0.13, MetaLR 0.17
- A5T (p.Ala5Thr), rs1262001260, gnomAD 2-60891685-G-A, REVEL 0.08, MetaLR 0.09
- A5V (p.Ala5Val), rs146326268, gnomAD 2-60891686-C-T, REVEL 0.03, MetaLR 0.07
- A5E (p.Ala5Glu), rs146326268, gnomAD 2-60891686-C-A, REVEL 0.07, MetaLR 0.05
- A5G (p.Ala5Gly), gnomAD 2-60891686-C-G, REVEL 0.04, MetaLR 0.05
- A5A (p.Ala5Ala), rs139585157, gnomAD 2-60891687-G-A, CADD 0.31
- Y6N (p.Tyr6Asn), gnomAD 2-60891688-T-A, REVEL 0.05, MetaLR 0.03
- Y6C (p.Tyr6Cys), gnomAD 2-60891689-A-G, REVEL 0.07, MetaLR 0.06
- Y6Y (p.Tyr6Tyr), gnomAD 2-60891690-T-C, CADD 6.53
- N7I (p.Asn7Ile), gnomAD 2-60891692-A-T, REVEL 0.03, MetaLR 0.06
- N7T (p.Asn7Thr), rs1234379831, gnomAD 2-60891692-A-C, REVEL 0.02, MetaLR 0.05
- N7K (p.Asn7Lys), gnomAD 2-60891693-C-A, REVEL 0.04, MetaLR 0.03
- P8S (p.Pro8Ser), NCI-TCGA Cosmic COSV5436, cosmic curated COSV54367, MetaLR 0.63, MetaSVM 0.40, Variant assessed as somatic; moderate impact.
- P8A (p.Pro8Ala), rs911836734, gnomAD 2-60891694-C-G, REVEL 0.37, MetaLR 0.51
- P8L (p.Pro8Leu), rs776656350, gnomAD 2-60891695-C-T, REVEL 0.55, MetaLR 0.63
- P8P (p.Pro8Pro), rs144201614, gnomAD 2-60891696-G-A, CADD 0.69
- Y9S (p.Tyr9Ser), gnomAD 2-60891698-A-C, REVEL 0.11, MetaLR 0.12
- Y9C (p.Tyr9Cys), rs868755436, gnomAD 2-60891698-A-G, REVEL 0.04, MetaLR 0.11
- I10V (p.Ile10Val), rs1390363101, TOPMed rs1390363101, gnomAD rs1390363101, REVEL 0.04, MetaLR 0.04, Uncertain significance, not specified
- I10T (p.Ile10Thr), rs367780559, gnomAD 2-60891701-T-C, REVEL 0.37, MetaLR 0.24
- I10M (p.Ile10Met), rs753006954, gnomAD 2-60891702-A-G, REVEL 0.09, MetaLR 0.14
- E11Q (p.Glu11Gln), rs1673220418, gnomAD 2-60891703-G-C, REVEL 0.07, MetaLR 0.07
- E11A (p.Glu11Ala), rs763065273, gnomAD 2-60891704-A-C, REVEL 0.42, MetaLR 0.31
- E11D (p.Glu11Asp), rs201045327, gnomAD 2-60891705-G-T, REVEL 0.19, MetaLR 0.17
- I12L (p.Ile12Leu), gnomAD 2-60891706-A-T, REVEL 0.51, MetaLR 0.51
- I12V (p.Ile12Val), rs920348659, gnomAD 2-60891706-A-G, REVEL 0.42, MetaLR 0.47
- I13L (p.Ile13Leu), NCI-TCGA TCGA novel, MetaLR 0.06, MetaSVM -1.05, Variant assessed as somatic; moderate impact.
- I13T (p.Ile13Thr), rs1304457448, gnomAD 2-60891710-T-C, REVEL 0.07, MetaLR 0.07
- I13I (p.Ile13Ile), gnomAD 2-60891711-T-C, CADD 8.62
- E14* (p.Glu14Ter), NCI-TCGA TCGA novel, CADD 38.00, Variant assessed as somatic; high impact.
- E14D (p.Glu14Asp), rs1359804880, gnomAD 2-60891714-A-C, REVEL 0.62, MetaLR 0.39
- E14E (p.Glu14Glu), gnomAD 2-60891714-A-G, CADD 8.84
- Q15E (p.Gln15Glu), rs1673220838, gnomAD 2-60891715-C-G, REVEL 0.36, MetaLR 0.36
- Q15Q (p.Gln15Gln), rs1434408624, gnomAD 2-60891717-A-G, CADD 8.19
- P16S (p.Pro16Ser), rs751670419, gnomAD 2-60891718-C-T, REVEL 0.90, MetaLR 0.76
- P16P (p.Pro16Pro), rs757261181, gnomAD 2-60891720-C-G, CADD 10.70
- R17K (p.Arg17Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R17R (p.Arg17Arg), gnomAD 2-60891723-G-A, CADD 9.04
- Q18Q (p.Gln18Gln), rs2103927557, gnomAD 2-60891726-G-A, CADD 7.53
- R19R (p.Arg19Arg), rs200474960, gnomAD 2-60891729-G-A, CADD 12.00
- G20R (p.Gly20Arg), NCI-TCGA Cosmic COSV9969, cosmic curated COSV99692, Ensembl rs2103927563, MetaLR 0.41, MetaSVM -0.13, Variant assessed as somatic; moderate impact.
- R22C (p.Arg22Cys), rs372213094, cosmic curated COSV54366, ESP rs372213094, AlphaMissense 1.00, MetaLR 0.64, Variant assessed as somatic; moderate impact.
- R22H (p.Arg22His), rs1558790056, TOPMed rs1558790056, AlphaMissense 1.00, MetaLR 0.67, Variant assessed as somatic; moderate impact.
- Y25Y (p.Tyr25Tyr), gnomAD 2-60891747-C-T, CADD 10.40
- K26T (p.Lys26Thr), NCI-TCGA Cosmic COSV5436, cosmic curated COSV54362, MetaLR 0.33, MetaSVM -0.32, Variant assessed as somatic; moderate impact.
- K26E (p.Lys26Glu), gnomAD 2-60891748-A-G, REVEL 0.29, MetaLR 0.16
- K26R (p.Lys26Arg), rs750889525, gnomAD 2-60891749-A-G, REVEL 0.36, MetaLR 0.33
- K26N (p.Lys26Asn), gnomAD 2-60891750-A-T, REVEL 0.36, MetaLR 0.31
- G29G (p.Gly29Gly), gnomAD 2-60891759-G-C, CADD 8.89
- R30* (p.Arg30Ter), NCI-TCGA Cosmic COSV5436, cosmic curated COSV54363, Ensembl rs2103927607, Variant assessed as somatic; high impact.
- R30P (p.Arg30Pro), gnomAD 2-60891761-G-C, REVEL 0.64, MetaLR 0.29
- R30Q (p.Arg30Gln), rs1673221568, gnomAD 2-60891761-G-A, REVEL 0.58, MetaLR 0.38
- R30R (p.Arg30Arg), rs1673221627, gnomAD 2-60891762-A-G, CADD 9.02
- A32V (p.Ala32Val), rs756541045, gnomAD 2-60891767-C-T, REVEL 0.57, MetaLR 0.41
- A32A (p.Ala32Ala), rs1389499300, gnomAD 2-60891768-A-G, CADD 10.10
- S34I (p.Ser34Ile), rs780257327, gnomAD 2-60891773-G-T, REVEL 0.75, MetaLR 0.46
- I35V (p.Ile35Val), rs1673221893, gnomAD 2-60891775-A-G, REVEL 0.43, MetaLR 0.36
- P36S (p.Pro36Ser), rs749613488, gnomAD 2-60891778-C-T, REVEL 0.43, MetaLR 0.36
- P36P (p.Pro36Pro), rs1187354315, gnomAD 2-60891780-A-G, CADD 8.20
- E38Q (p.Glu38Gln), NCI-TCGA Cosmic COSV5436, cosmic curated COSV54367, MetaLR 0.32, MetaSVM -0.52, Variant assessed as somatic; moderate impact.
- E38K (p.Glu38Lys), rs771878037, gnomAD 2-60891784-G-A, REVEL 0.45, MetaLR 0.27
- E38E (p.Glu38Glu), rs2103927695, gnomAD 2-60891786-G-A, CADD 9.31
- H39Y (p.His39Tyr), rs1673222161, gnomAD 2-60891787-C-T, REVEL 0.09, MetaLR 0.15
- H39R (p.His39Arg), rs1450937287, gnomAD 2-60891788-A-G, REVEL 0.06, MetaLR 0.04
- S40G (p.Ser40Gly), rs1673222296, gnomAD 2-60891790-A-G, REVEL 0.47, MetaLR 0.44
- T41T (p.Thr41Thr), rs1170373557, gnomAD 2-60891795-A-G, CADD 10.40
- D42V (p.Asp42Val), NCI-TCGA Cosmic COSV9969, cosmic curated COSV99692, MetaLR 0.26, MetaSVM -0.54, Variant assessed as somatic; moderate impact.
- D42D (p.Asp42Asp), rs200357067, gnomAD 2-60891798-C-T, CADD 7.45
- D42E (p.Asp42Glu), rs200357067, gnomAD 2-60891798-C-A, REVEL 0.10, MetaLR 0.06
- N43S (p.Asn43Ser), rs2466180897, ClinGen CA347041532, ClinVar RCV003037507, REVEL 0.16, MetaLR 0.06, Uncertain significance, not provided
- N44S (p.Asn44Ser), rs1414774075, gnomAD 2-60891803-A-G, REVEL 0.09, MetaLR 0.10
- N44N (p.Asn44Asn), rs746534505, gnomAD 2-60891804-C-T, CADD 8.32
- R45Q (p.Arg45Gln), rs1456684871, NCI-TCGA Cosmic COSV5436, cosmic curated COSV54362, gnomAD rs1456684871, REVEL 0.26, MetaLR 0.20, Variant assessed as somatic; moderate impact.
- R45R (p.Arg45Arg), rs147654074, gnomAD 2-60891805-C-A, CADD 10.50
- R45* (p.Arg45Ter), rs147654074, gnomAD 2-60891805-C-T, CADD 35.00
- I50T (p.Ile50Thr), NCI-TCGA Cosmic COSV9969, cosmic curated COSV99692, MetaLR 0.37, MetaSVM -0.09, Variant assessed as somatic; moderate impact.
- I50M (p.Ile50Met), gnomAD 2-60891822-C-G, REVEL 0.40, MetaLR 0.35
- I50I (p.Ile50Ile), gnomAD 2-60891822-C-T, CADD 6.69
- Q51H (p.Gln51His), gnomAD 2-60891825-G-C, REVEL 0.43, MetaLR 0.28
- I52F (p.Ile52Phe), gnomAD 2-60894397-A-T, REVEL 0.59, MetaLR 0.40
- I52V (p.Ile52Val), rs769651615, gnomAD 2-60894397-A-G, REVEL 0.09, MetaLR 0.09
- I52T (p.Ile52Thr), gnomAD 2-60894398-T-C, REVEL 0.81, MetaLR 0.40
- I52I (p.Ile52Ile), gnomAD 2-60894399-T-A, CADD 14.60
- M53V (p.Met53Val), rs61732856, gnomAD 2-60894400-A-G, REVEL 0.06, MetaLR 0.04
- M53L (p.Met53Leu), gnomAD 2-60894400-A-T, REVEL 0.05, MetaLR 0.02
- p.Met53 Asn54delinsIle, gnomAD 2-60894401-TGAA-T, CADD 19.40
- M53I (p.Met53Ile), gnomAD 2-60894401-TGA-T, CADD 26.50
- M53T (p.Met53Thr), rs1158932766, gnomAD 2-60894401-T-C, REVEL 0.08, MetaLR 0.07
- N54D (p.Asn54Asp), gnomAD 2-60894403-A-G, REVEL 0.39, MetaLR 0.29
- N54Y (p.Asn54Tyr), gnomAD 2-60894403-A-T, REVEL 0.70, MetaLR 0.37
- N54S (p.Asn54Ser), gnomAD 2-60894404-A-G, REVEL 0.48, MetaLR 0.34
- N54N (p.Asn54Asn), gnomAD 2-60894405-C-T, CADD 8.98
- N54K (p.Asn54Lys), gnomAD 2-60894405-C-A, REVEL 0.45, MetaLR 0.29
- Y55H (p.Tyr55His), rs762750452, gnomAD 2-60894406-T-C, REVEL 0.38, MetaLR 0.30
- Y55C (p.Tyr55Cys), gnomAD 2-60894407-A-G, REVEL 0.24, MetaLR 0.16
- Y55Y (p.Tyr55Tyr), rs192351726, gnomAD 2-60894408-T-C, CADD 5.16
- Y56H (p.Tyr56His), rs1354900743, gnomAD 2-60894409-T-C, REVEL 0.10, MetaLR 0.07
- Y56C (p.Tyr56Cys), rs1673296649, gnomAD 2-60894410-A-G, REVEL 0.12, MetaLR 0.04
- Y56Y (p.Tyr56Tyr), rs377365458, gnomAD 2-60894411-T-C, CADD 5.83
- G57R (p.Gly57Arg), gnomAD 2-60894412-G-A, REVEL 0.59, MetaLR 0.52
- G57V (p.Gly57Val), gnomAD 2-60894413-G-T, REVEL 0.56, MetaLR 0.52
- G57G (p.Gly57Gly), rs528753729, gnomAD 2-60894414-A-G, CADD 12.80
- K58N (p.Lys58Asn), gnomAD 2-60894417-A-C, REVEL 0.25, MetaLR 0.17
- K58K (p.Lys58Lys), rs1451805053, gnomAD 2-60894417-A-G, CADD 11.20
- p.Gly59 Lys60del, gnomAD 2-60894411-TGGAAA, CADD 21.10
- G59E (p.Gly59Glu), gnomAD 2-60894413-GA-G, CADD 26.00
- G59R (p.Gly59Arg), gnomAD 2-60894418-G-A, REVEL 0.22, MetaLR 0.17
- G59* (p.Gly59Ter), gnomAD 2-60894418-G-T, CADD 36.00
- G59V (p.Gly59Val), rs767728453, gnomAD 2-60894419-G-T, REVEL 0.25, MetaLR 0.09
- G59A (p.Gly59Ala), rs767728453, gnomAD 2-60894419-G-C, REVEL 0.21, MetaLR 0.06
- G59G (p.Gly59Gly), gnomAD 2-60894420-A-G, CADD 13.30
- K60R (p.Lys60Arg), gnomAD 2-60894422-A-G, REVEL 0.17, MetaLR 0.10
- K60K (p.Lys60Lys), gnomAD 2-60894423-A-G, CADD 12.10
- V61* (p.Val61Ter), gnomAD 2-60894419-GA-G, CADD 25.30
- V61V (p.Val61Val), rs909663728, gnomAD 2-60894426-G-A, CADD 8.64
- R62G (p.Arg62Gly), gnomAD 2-60894427-A-G, REVEL 0.54, MetaLR 0.35
- R62K (p.Arg62Lys), rs1190862054, gnomAD 2-60894428-G-A, REVEL 0.36, MetaLR 0.26
- I63I (p.Ile63Ile), gnomAD 2-60894432-T-C, CADD 10.10
- T64A (p.Thr64Ala), gnomAD 2-60894433-A-G, REVEL 0.21, MetaLR 0.23
- T64K (p.Thr64Lys), gnomAD 2-60894434-C-A, REVEL 0.32, MetaLR 0.26
- T64I (p.Thr64Ile), rs1472110849, gnomAD 2-60894434-C-T, REVEL 0.31, MetaLR 0.26
- T64T (p.Thr64Thr), rs6729789, gnomAD 2-60894435-A-G, CADD 7.77
- V66L (p.Val66Leu), rs760737163, gnomAD 2-60894439-G-C, REVEL 0.48, MetaLR 0.40
- V66V (p.Val66Val), rs1262962980, gnomAD 2-60894441-A-T, CADD 8.87
- T67A (p.Thr67Ala), gnomAD 2-60894442-A-G, REVEL 0.67, MetaLR 0.37
- T67K (p.Thr67Lys), gnomAD 2-60894443-C-A, REVEL 0.75, MetaLR 0.42
- T67T (p.Thr67Thr), gnomAD 2-60894444-A-G, CADD 9.71
- N69S (p.Asn69Ser), rs1200272344, gnomAD 2-60894449-A-G, REVEL 0.10, MetaLR 0.06
- D70Y (p.Asp70Tyr), gnomAD 2-60894451-G-T, REVEL 0.29, MetaLR 0.21
- D70G (p.Asp70Gly), rs1318742066, gnomAD 2-60894452-A-G, REVEL 0.22, MetaLR 0.14
- D70D (p.Asp70Asp), gnomAD 2-60894453-C-T, CADD 8.69
- D70E (p.Asp70Glu), gnomAD 2-60894453-C-A, REVEL 0.14, MetaLR 0.02
- P71A (p.Pro71Ala), gnomAD 2-60894454-C-G, REVEL 0.55, MetaLR 0.37
- P71T (p.Pro71Thr), gnomAD 2-60894454-C-A, REVEL 0.51, MetaLR 0.35
- P71Q (p.Pro71Gln), gnomAD 2-60894455-C-A, REVEL 0.49, MetaLR 0.35
- Y72C (p.Tyr72Cys), rs184939650, gnomAD 2-60894458-A-G, REVEL 0.27, MetaLR 0.23
- K73N (p.Lys73Asn), gnomAD 2-60894459-TA-T, CADD 27.30
- K73R (p.Lys73Arg), gnomAD 2-60894461-A-G, REVEL 0.16, MetaLR 0.09
- P74H (p.Pro74His), gnomAD 2-60894464-C-A, REVEL 0.74, MetaLR 0.41
- P74P (p.Pro74Pro), gnomAD 2-60894465-T-C, CADD 10.20
- H75P (p.His75Pro), gnomAD 2-60894467-A-C, REVEL 0.88, MetaLR 0.64
- H75H (p.His75His), rs1414699898, gnomAD 2-60894468-T-C, CADD 9.36
- P76T (p.Pro76Thr), gnomAD 2-60894469-C-A, REVEL 0.64, MetaLR 0.38
- H77Y (p.His77Tyr), gnomAD 2-60894472-C-T, REVEL 0.78, MetaLR 0.49
- D78D (p.Asp78Asp), gnomAD 2-60894477-T-C, CADD 8.18
- L79L (p.Leu79Leu), rs1258115812, gnomAD 2-60894480-A-G, CADD 8.97
- V80V (p.Val80Val), rs1211697703, gnomAD 2-60894483-T-C, CADD 10.70
- K82R (p.Lys82Arg), gnomAD 2-60894488-A-G, REVEL 0.27, MetaLR 0.27
- K82K (p.Lys82Lys), rs1035553007, gnomAD 2-60894489-A-G, CADD 11.40
- D83T (p.Asp83Thr), gnomAD 2-60894485-GA-G, CADD 23.70
- D83N (p.Asp83Asn), gnomAD 2-60894490-G-A, REVEL 0.36, MetaLR 0.30
- D83E (p.Asp83Glu), rs747058897, gnomAD 2-60894492-C-A, REVEL 0.28, MetaLR 0.17
- C84C (p.Cys84Cys), rs1036739383, gnomAD 2-60894495-C-T, CADD 13.30
- R85G (p.Arg85Gly), gnomAD 2-60894496-A-G, REVEL 0.25, MetaLR 0.17
- R85T (p.Arg85Thr), gnomAD 2-60894497-G-C, REVEL 0.15, MetaLR 0.16
- D86D (p.Asp86Asp), rs369870559, gnomAD 2-60894501-C-T, CADD 9.95
- G87S (p.Gly87Ser), gnomAD 2-60894502-G-A, REVEL 0.65, MetaLR 0.42
- Y88C (p.Tyr88Cys), rs918803156, gnomAD 2-60894506-A-G, REVEL 0.25, MetaLR 0.22
- Y88S (p.Tyr88Ser), gnomAD 2-60894506-A-C, REVEL 0.26, MetaLR 0.23
- Y88Y (p.Tyr88Tyr), gnomAD 2-60894507-C-T, CADD 9.43
- Y89S (p.Tyr89Ser), gnomAD 2-60894509-A-C, REVEL 0.52, MetaLR 0.29
- E90E (p.Glu90Glu), gnomAD 2-60894513-A-G, CADD 12.90
- A91T (p.Ala91Thr), gnomAD 2-60894514-G-A, REVEL 0.21, MetaLR 0.27
- A91V (p.Ala91Val), gnomAD 2-60894515-C-T, REVEL 0.23, MetaLR 0.11
- E92E (p.Glu92Glu), gnomAD 2-60894519-A-G, CADD 9.48
- G94E (p.Gly94Glu), rs2466189964, ClinGen CA347041899, ClinVar RCV004443806, Uncertain significance, not specified
- G94R (p.Gly94Arg), rs765668256, gnomAD 2-60894523-G-A, REVEL 0.41, MetaLR 0.25
- G94G (p.Gly94Gly), rs1673298752, gnomAD 2-60894525-A-G, CADD 11.30
- Q95E (p.Gln95Glu), rs1673298837, gnomAD 2-60894526-C-G, REVEL 0.08, MetaLR 0.09
Public REL analysis runs
- REL analysis run — REL (278 variants) — completed 2026-08-19